SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

NeuroBo Pharmaceuticals Q1 EPS $(0.300) Up From $(0.480) YoY

NeuroBo Pharmaceuticals (NASDAQ:NRBO) reported quarterly losses of $(0.300) per share. This is a 37.5 percent increase over losses of $(0.480) per share from the same period last year.

Benzinga · 05/20/2020 20:30

NeuroBo Pharmaceuticals (NASDAQ:NRBO) reported quarterly losses of $(0.300) per share. This is a 37.5 percent increase over losses of $(0.480) per share from the same period last year.